Prudential Financial Inc Akebia Therapeutics, Inc. Transaction History

Prudential Financial Inc

  • $70 Billion
  • Q3 2024

A detailed history of Prudential Financial Inc transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Prudential Financial Inc holds 64,469 shares of AKBA stock, worth $122,491. This represents 0.0% of its overall portfolio holdings.

Number of Shares
64,469
Previous 14,269 351.81%
Holding current value
$122,491
Previous $14,000 507.14%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$0.94 - $1.55 $47,188 - $77,810
50,200 Added 351.81%
64,469 $85,000
Q2 2024

Aug 13, 2024
SELL
$0.86 - $1.63 $20,502 - $38,859
-23,840 Reduced 62.56%
14,269 $14,000
Q1 2024

May 14, 2024
BUY
$1.27 - $2.24 $20,320 - $35,840
16,000 Added 72.37%
38,109 $69,000
Q4 2023

Feb 13, 2024
SELL
$0.8 - $1.28 $20,320 - $32,512
-25,400 Reduced 53.46%
22,109 $27,000
Q2 2023

Aug 11, 2023
BUY
$0.51 - $1.43 $24,229 - $67,937
47,509 New
47,509 $43,000
Q2 2022

Aug 15, 2022
SELL
$0.32 - $0.67 $79,971 - $167,441
-249,912 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$0.72 - $2.93 $274,320 - $1.12 Million
-381,000 Reduced 60.39%
249,912 $177,000
Q4 2021

Feb 14, 2022
SELL
$2.26 - $3.34 $1.02 Million - $1.51 Million
-452,993 Reduced 41.79%
630,912 $1.43 Million
Q3 2021

Nov 15, 2021
BUY
$2.35 - $3.88 $2.5 Million - $4.12 Million
1,062,864 Added 5051.39%
1,083,905 $3.12 Million
Q2 2021

Aug 16, 2021
BUY
$2.83 - $4.2 $7,513 - $11,151
2,655 Added 14.44%
21,041 $80,000
Q1 2021

May 12, 2021
BUY
$2.92 - $5.06 $175 - $303
60 Added 0.33%
18,386 $62,000
Q3 2020

Nov 16, 2020
BUY
$2.39 - $13.08 $15,915 - $87,099
6,659 Added 57.08%
18,326 $46,000
Q2 2020

Aug 12, 2020
SELL
$6.67 - $13.58 $7,290 - $14,842
-1,093 Reduced 8.57%
11,667 $158,000
Q4 2019

Feb 11, 2020
BUY
$3.16 - $6.73 $5,056 - $10,768
1,600 Added 14.34%
12,760 $80,000
Q3 2019

Nov 13, 2019
BUY
$3.55 - $5.4 $4,057 - $6,172
1,143 Added 11.41%
11,160 $43,000
Q2 2019

Aug 08, 2019
SELL
$4.1 - $8.05 $51,413 - $100,947
-12,540 Reduced 55.59%
10,017 $0
Q1 2019

May 15, 2019
SELL
$5.41 - $8.73 $13,395 - $21,615
-2,476 Reduced 9.89%
22,557 $0
Q4 2018

Feb 07, 2019
BUY
$5.39 - $9.15 $35,967 - $61,057
6,673 Added 36.35%
25,033 $138,000
Q3 2018

Nov 07, 2018
SELL
$7.44 - $10.65 $3,050 - $4,366
-410 Reduced 2.18%
18,360 $0
Q2 2018

Aug 13, 2018
SELL
$9.15 - $11.34 $279,898 - $346,890
-30,590 Reduced 61.97%
18,770 $0
Q3 2017

Nov 02, 2017
BUY
$13.06 - $19.67 $644,641 - $970,911
49,360
49,360 $971,000

Others Institutions Holding AKBA

# of Institutions
121
Shares Held
54.6M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $349M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Prudential Financial Inc Portfolio

Follow Prudential Financial Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email